Clinical Trials Browser

OTHER × Interventional × Technetium Tc 99m Sestamibi × Clear all

NCT02744053 2026-04-21

DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer

Phase EARLY_PHASE1 Active not recruiting

Triple Negative Breast Neoplasms

NCT05042687 2026-04-15

Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer

Phase NA Recruiting

Breast Neoplasms

NCT02324387 2026-03-09

Tc99m Sestamibi Molecular Breast Imaging

Phase NA Active not recruiting

Breast Neoplasms

NCT06058650 2025-09-30

Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities

Phase NA Recruiting

Breast Neoplasms

NCT00560495 2022-10-03

Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Phase 1 Withdrawn

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03065218 2022-07-26

99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients

Phase 4 Terminated

4 enrolled 5 charts

Thyroid Diseases, Thyroid Neoplasms

NCT01925170 2014-08-19

Low Dose Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts

Phase NA Completed

1,638 enrolled 15 charts

Breast Neoplasms

NCT00620373 2014-08-01

Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts

Phase NA Completed

969 enrolled 12 charts

Breast Neoplasms